Clinical trials
Observational Macular Degeneration trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universitaire Ziekenhuizen KU Leuven | 3 |
| Brugmann University Hospital | 1 |
| Laurence Postelmans | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 7 |
| Alzheimer Disease | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Diabetic Retinopathy | 1 |
| Glaucoma | 1 |
| Retinal Vein Occlusion | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.